Proteintech

MAD2L1 antibody

#10337-1-AP · western blot · $449

9
Citing papers
102
Combined citations
Supplier page Find this product

Research areas

Microtubule and mitosis dynamics3Peptidase Inhibition and Analysis2Endometriosis Research and Treatment1Extracellular vesicles in disease1Genetic and Kidney Cyst Diseases1Genomics and Chromatin Dynamics1Hereditary Neurological Disorders1Endoplasmic Reticulum Stress and Disease1

Papers citing this product

1
KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells
Oncogene·2018·73 cit.·DOI
2
Exosomal miR-493 suppresses MAD2L1 and induces chemoresistance to intraperitoneal paclitaxel therapy in gastric cancer patients with peritoneal metastasis
Scientific Reports·2024·11 cit.·DOI
3
Kinesin Family Member-18A (KIF18A) Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma
Digestive Diseases and Sciences·2024·7 cit.·DOI
4
CCDC68 Maintains Mitotic Checkpoint Activation by Promoting CDC20 Integration into the MCC
Advanced Science·2024·3 cit.·DOI
5
MAD2L1 supports MYC-driven liver carcinogenesis in mice and predicts poor prognosis in human hepatocarcinoma
Toxicological Sciences·2024·3 cit.·DOI
6
BAG2, MAD2L1, and MDK are cancer-driver genes and candidate targets for novel therapies in malignant pleural mesothelioma
Cancer Gene Therapy·2024·2 cit.·DOI
7
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma
Cell Death and Disease·2024·2 cit.·DOI
8
A Novel FGFR3‐Targeting Antibody‐Drug Conjugate Induces Tumor Cell Apoptosis through the cGAS–STING Pathway in Bladder Cancer
Advanced Science·2025·1 cit.·DOI
9
エクソソーム由来のmiR-493はMAD2L1の抑制を介して腹膜転移を有する胃癌患者へのパクリタキセルの腹腔内投与療法への抵抗性を惹起する
Institutional Repositories DataBase (IRDB)·2024

Similar products

ProductVendorPricePapers
MAD2L1 (D8A7) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$161100
MAD2L1 antibody — Evidence — PubIndex